Verition Fund Management’s Cocrystal Pharma COCP Stock Holding History

Verition Fund Management’s Portfolio COCP Stock Details COCP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,333	Closed	-$47K	–	2239
2022 Q3	$47K	Hold	13,333	–	–	﹤0.01%	2697
2022 Q2	$66K	Hold	13,333	–	–	﹤0.01%	2119
2022 Q1	$88K	Hold	13,333	–	–	﹤0.01%	2450
2021 Q4	$104K	Hold	13,333	–	–	﹤0.01%	2331
2021 Q3	$168K	Hold	13,333	–	–	﹤0.01%	1637
2021 Q2	$200K	Sell	13,333 -1,667	-11%	-$25.3K	﹤0.01%	1584
2021 Q1	$250K	Hold	15,000	–	–	﹤0.01%	1215
2020 Q4	$245K	Hold	15,000	–	–	﹤0.01%	900
2020 Q3	$167K	Buy	15,000 +10,833	+260%	+$198K	﹤0.01%	959
2020 Q2	$76K	Hold	4,167	–	–	﹤0.01%	1012
2020 Q1	$36K	Buy	+4,167	New	+$39.2K	﹤0.01%	547

Other funds holding COCP

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management's COCP Position: Q4 2022 in Review

Verition Fund Management sold out of Cocrystal Pharma (COCP) in Q4 2022, closing a stake of 13,333 shares — an estimated $47K sold.

Verition Fund Management first reported a position in COCP in Q1 2020 and held it in 11 quarters. The position peaked at $250K in Q1 2021. 21 funds tracked by Wall St. Rank hold COCP as of Q4 2022.

Verition Fund Management reported no remaining Cocrystal Pharma position as of Q4 2022 after selling out during the quarter.
Verition Fund Management sold 13,333 Cocrystal Pharma shares in Q4 2022, an estimated $47K.
Verition Fund Management first reported a position in Cocrystal Pharma in Q1 2020 and held it in 11 quarters.
Verition Fund Management's Cocrystal Pharma position peaked at $250K in Q1 2021.
21 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2022.

Based on Verition Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.